Laura Shawver's Net Worth

$34.5 Million

Estimate Recalculated Apr 29, 2024 07:37PM EST

Who is Laura Shawver?

Laura Shawver has an estimated net worth of $34.5 Million. This is based on reported shares across multiple companies, which include Nkarta, Inc., Relay Therapeutics, Inc., Synthorx, Inc., ARS Pharmaceuticals, Inc., and CORNERSTONE THERAPEUTICS INC.

SEC CIK

Laura Shawver's CIK is 0001551891

Past Insider Trading and Trends

2023 was Laura Shawver's most active year for acquiring shares with 16 total transactions. Laura Shawver's most active month to acquire stocks was the month of April. 2023 was Laura Shawver's most active year for disposing of shares, totalling 28 transactions. Laura Shawver's most active month to dispose stocks was the month of July. 2019 saw Laura Shawver paying a total of $1,541,069.14 for 449,453 shares, this is the most they've acquired in one year. In 2020 Laura Shawver cashed out on 1,176,927 shares for a total of $69,924,812.07, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nkarta, Inc. (NKTX) Snapshot price: $10.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jul 9
Form 3
—
0
—
—
0
No matching records found

Relay Therapeutics, Inc. (RLAY) Snapshot price: $9.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 31
Form 4
-23.22%
-12.10K
—
—
40K
May 24
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
No matching records found

Synthorx, Inc. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-60.21%
-326.30K
$68.00
-$16,700,460.00
215.59K
Jan 8 - Jan 23
Form 4
+133.57%
169.44K
$37.32
-$13,307,687.16
296.3K
Dec 30
Form 4
+54.97%
45K
—
—
126.86K
Dec 18
Form 4
∞
25K
$0.63
$15,750.00
25K
Jan 24
Form 4
—
0
—
—
0
Dec 6
Form 3
—
0
—
—
0
No matching records found

ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $6.31

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$4.49
-$643,520.00
210.35K
Sep 1
Form 4
—
0
$4.15
-$259,334.22
210.35K
Aug 3 - Aug 4
Form 4
—
0
$4.20
-$321,995.84
210.35K
Aug 1 - Aug 2
Form 4
—
0
$3.82
-$45,122.65
210.35K
Jul 7
Form 4
—
0
$3.88
-$474,702.96
210.35K
Jul 3 - Jul 6
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
$4.06
-$557,041.15
210.35K
Jun 1 - Jun 2
Form 4
-17.27%
-43.90K
$3.35
-$653,578.68
210.35K
Nov 9 - May 9
Form 4
+44.87%
78.74K
$1.27
$99,999.80
254.24K
Aug 5
Form 4
+63.42%
68.11K
—
—
175.5K
May 2
Form 4
+34.42%
27.5K
—
—
107.39K
Feb 1
Form 4
—
0
—
—
0
Dec 3
Form 3
—
0
—
—
0
No matching records found

CORNERSTONE THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Jun 6
Form 3
—
0
—
—
0
No matching records found